These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 38016139)

  • 1. Predicting recurrence and survival in patients with non-metastatic renal-cell carcinoma after nephrectomy: a prospective population-based study with multicenter validation.
    Wang Y; Xuan Y; Su B; Gao Y; Fan Y; Huang Q; Zhang P; Gu L; Niu S; Shen D; Li X; Wang B; Zhu Q; Ouyang Z; Xie J; Ma X
    Int J Surg; 2024 Feb; 110(2):820-831. PubMed ID: 38016139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and validation of a nomogram to predict overall survival for patients with metastatic renal cell carcinoma.
    Zheng W; Zhu W; Yu S; Li K; Ding Y; Wu Q; Tang Q; Zhao Q; Lu C; Guo C
    BMC Cancer; 2020 Nov; 20(1):1066. PubMed ID: 33148204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic models for newly-diagnosed chronic lymphocytic leukaemia in adults: a systematic review and meta-analysis.
    Kreuzberger N; Damen JA; Trivella M; Estcourt LJ; Aldin A; Umlauff L; Vazquez-Montes MD; Wolff R; Moons KG; Monsef I; Foroutan F; Kreuzer KA; Skoetz N
    Cochrane Database Syst Rev; 2020 Jul; 7(7):CD012022. PubMed ID: 32735048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Establishment and validation of a novel nomogram to predict overall survival after radical nephrectomy].
    Xiong LB; Zou XP; Ning K; Luo X; Peng YL; Zhou ZH; Wang J; Li Z; Yu CP; Dong P; Guo SJ; Han H; Zhou FJ; Zhang ZL
    Zhonghua Zhong Liu Za Zhi; 2023 Aug; 45(8):681-689. PubMed ID: 37580273
    [No Abstract]   [Full Text] [Related]  

  • 5. Predicting Disease Recurrence, Early Progression, and Overall Survival Following Surgical Resection for High-risk Localized and Locally Advanced Renal Cell Carcinoma.
    Correa AF; Jegede OA; Haas NB; Flaherty KT; Pins MR; Adeniran A; Messing EM; Manola J; Wood CG; Kane CJ; Jewett MAS; Dutcher JP; DiPaola RS; Carducci MA; Uzzo RG
    Eur Urol; 2021 Jul; 80(1):20-31. PubMed ID: 33707112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and External Validation of a Novel Nomogram Predicting Cancer-specific Mortality-free Survival in Surgically Treated Papillary Renal Cell Carcinoma Patients.
    Piccinelli ML; Barletta F; Tappero S; Cano Garcia C; Incesu RB; Morra S; Scheipner L; Tian Z; Luzzago S; Mistretta FA; Ferro M; Saad F; Shariat SF; Ahyai S; Longo N; Tilki D; Chun FKH; Terrone C; Briganti A; de Cobelli O; Musi G; Karakiewicz PI
    Eur Urol Focus; 2023 Sep; 9(5):799-806. PubMed ID: 37024421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and internal validation of nomograms for the prediction of postoperative survival of patients with grade 4 renal cell carcinoma (RCC).
    Zhu J; Liu Z; Zhang Z; Fan Y; Chen Y; He Z; Zhou L; Jin J; Shen C; Yu W
    Transl Androl Urol; 2020 Dec; 9(6):2629-2639. PubMed ID: 33457235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. External validation of the updated Leibovich prognostic models for clear cell and papillary renal cell carcinoma in an Asian population.
    Lee HJ; Lee A; Huang HH; Lau WKO
    Urol Oncol; 2019 Jun; 37(6):356.e9-356.e18. PubMed ID: 30905510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predicting Oncologic Outcomes in Renal Cell Carcinoma After Surgery.
    Leibovich BC; Lohse CM; Cheville JC; Zaid HB; Boorjian SA; Frank I; Thompson RH; Parker WP
    Eur Urol; 2018 May; 73(5):772-780. PubMed ID: 29398265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preoperative systemic inflammation response index indicates poor prognosis in patients treated with resection of renal cell carcinoma with inferior vena cava tumor thrombus.
    Lv Z; Feng HY; Wang T; Ma X; Zhang X
    Urol Oncol; 2022 Apr; 40(4):167.e9-167.e19. PubMed ID: 35042663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of Machine Learning Models to Predict Recurrence After Surgical Resection of Nonmetastatic Renal Cell Carcinoma.
    Khene ZE; Bigot P; Doumerc N; Ouzaid I; Boissier R; Nouhaud FX; Albiges L; Bernhard JC; Ingels A; Borchiellini D; Kammerer-Jacquet S; Rioux-Leclercq N; Roupret M; Acosta O; De Crevoisier R; Bensalah K;
    Eur Urol Oncol; 2023 Jun; 6(3):323-330. PubMed ID: 35987730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictive value of single-nucleotide polymorphism signature for recurrence in localised renal cell carcinoma: a retrospective analysis and multicentre validation study.
    Wei JH; Feng ZH; Cao Y; Zhao HW; Chen ZH; Liao B; Wang Q; Han H; Zhang J; Xu YZ; Li B; Wu JT; Qu GM; Wang GP; Liu C; Xue W; Liu Q; Lu J; Li CX; Li PX; Zhang ZL; Yao HH; Pan YH; Chen WF; Xie D; Shi L; Gao ZL; Huang YR; Zhou FJ; Wang SG; Liu ZP; Chen W; Luo JH
    Lancet Oncol; 2019 Apr; 20(4):591-600. PubMed ID: 30880070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma Glycosaminoglycans as Diagnostic and Prognostic Biomarkers in Surgically Treated Renal Cell Carcinoma.
    Gatto F; Blum KA; Hosseini SS; Ghanaat M; Kashan M; Maccari F; Galeotti F; Hsieh JJ; Volpi N; Hakimi AA; Nielsen J
    Eur Urol Oncol; 2018 Oct; 1(5):364-377. PubMed ID: 31158075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. External validation of a predictive model of survival after cytoreductive nephrectomy for metastatic renal cell carcinoma.
    Marconi L; de Bruijn R; van Werkhoven E; Beisland C; Fife K; Heidenreich A; Kapoor A; Karam J; Kauffmann C; Klatte T; Ljungberg B; Matin S; Sjoberg D; Staehler M; Stewart GD; Tanguay S; Uzzo R; Welsh S; Wood L; Wood C; Bex A
    World J Urol; 2018 Dec; 36(12):1973-1980. PubMed ID: 30069581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. External Validation of the 2003 Leibovich Prognostic Score in Patients Randomly Assigned to SORCE, an International Phase III Trial of Adjuvant Sorafenib in Renal Cell Cancer.
    Oza B; Eisen T; Frangou E; Stewart GD; Bex A; Ritchie AWS; Kaplan R; Smith B; Davis ID; Stockler MR; Albiges L; Escudier B; Larkin J; Joniau S; Hancock B; Hermann GG; Bellmunt J; Parmar MKB; Royston P; Meade A
    J Clin Oncol; 2022 Jun; 40(16):1772-1782. PubMed ID: 35213214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chromophobe renal cell carcinoma (RCC): oncological outcomes and prognostic factors in a large multicentre series.
    Volpe A; Novara G; Antonelli A; Bertini R; Billia M; Carmignani G; Cunico SC; Longo N; Martignoni G; Minervini A; Mirone V; Simonato A; Terrone C; Zattoni F; Ficarra V; ;
    BJU Int; 2012 Jul; 110(1):76-83. PubMed ID: 22044519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predicting Renal Cancer Recurrence: Defining Limitations of Existing Prognostic Models With Prospective Trial-Based Validation.
    Correa AF; Jegede O; Haas NB; Flaherty KT; Pins MR; Messing EM; Manola J; Wood CG; Kane CJ; Jewett MAS; Dutcher JP; DiPaola RS; Carducci MA; Uzzo RG
    J Clin Oncol; 2019 Aug; 37(23):2062-2071. PubMed ID: 31216227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation and Comparison of Prognostic Models in Renal Carcinoma in a Tertiary Hospital.
    Sanz Del Pozo M; Orlandi Oliveira W; Linacero Gracia Á; Sánchez Zalabardo JM; Gil Sanz MJ; Sáez Gutiérrez MB; Borque Fernando Á
    Arch Esp Urol; 2024 Jul; 77(6):622-631. PubMed ID: 39104229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and prognostic value of FBXO11 expression in patients with clear cell renal cell carcinoma.
    Fan B; Wang W; Zhang X; Sun M; Wang X; Chen Z; Liu W; Wang Q; Yu N; Li X
    BMC Cancer; 2019 Jun; 19(1):534. PubMed ID: 31159774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histological subtype of renal cell carcinoma significantly affects survival in the era of partial nephrectomy.
    Nguyen DP; Vertosick EA; Corradi RB; Vilaseca A; Benfante NE; Touijer KA; Sjoberg DD; Russo P
    Urol Oncol; 2016 Jun; 34(6):259.e1-8. PubMed ID: 26947350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.